Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5530 Wisconsin Ave
Ste 1150
Chevy Chase, MD 20815Phone+1 301-656-7374Fax+1 301-656-1019
Education & Training
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1991
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1990
- University of California (San Francisco)Residency, Internal Medicine, 1983 - 1986
- University of Miami Leonard M. Miller School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1985 - Present
- MD State Medical License 1991 - 2026
- DC State Medical License 1991 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification RcopiaMU EHR, DrFirst.com, Inc., 2011-2013
Publications & Presentations
PubMed
- 4 citationsBenralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, Trung N Tran, David Cohen
The European Respiratory Journal. 2024-07-01 - 83 citationsEffect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a mu...Richard J. Russell, Latifa Chachi, J. Mark FitzGerald, Vibeke Backer, Ronald Olivenstein
The Lancet. Respiratory Medicine. 2018-07-01 - 43 citationsTralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.William W. Busse, Guy Brusselle, Stephanie Korn, Piotr Kuna, Antoine Magnan
The European Respiratory Journal. 2019-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: